We have made transgenic tobacco plants (Nicotiana tabacum, cv. Xanthi nc) expressing the movement protein (P3, 300 amino acids) of alfalfa mosaic virus (AIMV) and two N-terminally deleted proteins lacking respectively 12 and 77 amino acids of the P3 sequence (P3A [1][2][3][4][5][6][7][8][9][10][11][12] and P3A ). The same proteins were expressed in recombinant yeast. By subcellular fractionation, the full-length P3 protein expressed by transgenic plants was found to be associated with cell walls as well as with cytoplasmic particulate material, as was the wild type movement protein expressed by AIMV-infected tobacco plants. P3A[1-12] behaved similarly but P3A was found only in the cytoplasm. It thus appears that a polypeptide domain located between amino acids 13 and 77 of the P3 sequence is necessary for association of the protein with cell walls.
Introduction
The 32K non-structural protein of alfalfa mosaic virus (A1MV) encoded by RNA3, designated P3, is thought to be the movement protein (MP) of this virus (Dore et al., 1991 ; van der Kuyl et al., 1991) , i.e. the protein which enables the infectious agent to be transported from the infected cells to the surrounding healthy cells. In infected cells, P3 was found to be associated with cell walls as well as with the cytoplasm (Godefroy-Colburn et al., 1986 Stussi-G~raud et al., 1987) . Serial sectioning and immunoelectron microscopy showed that the major part of the cell wall-associated protein was located in the vicinity of plasmodesmata (C. Stussi-Garaud, unpublished results), as are several other viral MPs (Hull, 1989; Atabekov & Taliansky, 1990) . This suggests that P3 and other MPs have a direct action on plasmodesmata. Indeed the MP of tobacco mosaic virus (TMV) has been shown to increase the molecular size exclusion limit of these structures in transgenic plants (Wolf et al., 1989) . The mechanism of action of the MP seems to vary according to the virus. In this respect, viruses can be divided into two main categories: those which move from cell to cell as non-encapsidated RNA and those which require their coat protein for cell-to-cell movement Goldbach et al., 1990; Harrison et al., 1990) . Thus far, the best studied MP is t Present address: Friedrich-Miescher Institute, P.O. Box 2543, Switzerland. that of TMV, a typical member of the former category. We thought it worthwhile to perform a parallel study on the MP of AIMV which, like viruses of the latter category, seems to require the coat protein for cell-to-cell movement (van der Kuyl et al., 1991) .
One of the essential features of MPs appears to be their ability to associate with cell walls and plasmodesmata. The identification of the polypeptide domains responsible for this association would be quite valuable, inasmuch as it would allow the design and the expression in transgenic plants of non-functional derivatives of the MPs which would retain the property to interact with their (still undefined) target. The modified proteins should reduce the ability of a challenging virus to move from cell to cell by competing with the viral MP or by blocking the cellular targets. In the case of TMV, Berna et al. (1991) identified a C-proximal domain of the MP which governs subcellular localization (or stability of the protein) as well as function. Here, we report the production of transgenic plants expressing the full-length MP of A1MV and two N-terminally deleted proteins derived from it, and present evidence that an Nproximal domain of the MP is necessary for association with cell walls.
HaelII digestion of plasmid 3pT7-1. The latter, a complete cDNA clone of RNA3 from strain S of A1MV (Dore & Pinck, 1988) , was the precursor of infectious clone 3BS(1,0) (Dore et al., 1990) Fragments coding for N-terminally deleted proteins were obtained by XhoI restriction (after nucleotide 24 of the coding sequence) or DraI restriction (after nucleotide 224 of the coding sequence). The resulting deleted ORFs started at the second and sixth methionine codons respectively of the complete ORF. The encoded proteins lacked 12 and 77 amino acids and were respectively designated P3A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] and P3A . Note that the DraI site used for this operation (present in both M 13mp7. P3 and 3pT7-1), was absent from the RNA3 clone sequenced by Ravelonandro et al. (1984) . Its exact position was determined by sequencing. It was thus found that, in the vicinity of nucleotide 224, plasmid 3pT7-1 was identical to the clone of RNA3 from strain 425 sequenced by Barker et al. (1983) . In addition, the RNA3 clones from strain S contained two DraI sites, 55 and 71 nucleotides respectively upstream from the initiation site (Ravelonandro et al., 1984) , which were used to shorten the untranslated leader sequence for expression in yeast.
Yeast expression plasmids were constructed by insertion of the three ORFs into shuttle vectors of the pVT series (Vernet et al., 1987) . The full-length P3 ORF (carrying 55 nucleotides of the untranslated leader) and the fragment coding for P3A , excised from M I 3rap7. P3 by BamHI and either partial or complete Dral digestions, were inserted between the PvulI and BamHI sites of pVTI01-U (carrying the URA3 gene for selection in yeast). The fragment coding for P3A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] , prepared from 3pT7-1 by digestion with J(hoI and HaellI, was ligated between the l"hoI and PoulI sites of pVTI03-L (carrying the LEU2 gene as selection marker). After selection and amplification in Escherichia coil C600-5K, the recombinant plasmids (designated pVT.P3, pVT.P3A and pVT.P3All-12] respectively) were purified by sedimentation through CsC1 gradients.
Plant transformation plasmids were constructed by insertion of the three ORFs into the integrative shuttle vector pMON316 (Sanders et al., 1987) . The full-length ORF (carrying 202 untranslated nucleotides at its 5' end) was excised from M 13mp7. P3 by EcoRI and ligated into the EcoRI site ofpMON316. A recombinant plasmid with the P30RF in the sense orientation was selected by HindIII restriction mapping and designated pMON.P3. An insert coding for P3All-771 was prepared from M13mp7. P3 by DraI and EcoRI digestions. An insert coding for P3A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] The cloning techniques were as described by Maniatis et al. (1982) .
Yeast transformation. The pVT-derived plasmids were introduced into Saccharomyces cerevisiae as described in Chevallier et al. (1980) . Strain NC93 (mutated in the URA3 gene) was transformed by pVT. P3 and pVT.P3A and selected on minimal medium (1 ~ glucose; 0-67~ yeast nitrogen base without amino acids); strain GRF18 (mutated in the LEU2 and HIS3 genes) was transformed by pVT. P3A [I-12] and selected on minimal medium supplemented with 100 gg/ml histidine.
Plant transformation. The pMON-derived plasmids were mobilized into Agrobacterium tumefaciens strain GV3111SE as described in Rogers et al. (1988) . The agrobacteria carrying recombinant Ti plasmids were selected on chloramphenicol, kanamycin and spectinomycin plates and inoculated to leaf fragments of Nicotiana tabacum (cv. Xanthi nc), then transformed plants were allowed to regenerate in the presence of kanamycin (Horsch et aL, 1985) .
Preparation of an antiserum against P3A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . The deleted protein P3A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] was purified from glass-bead homogenates of expressor yeast as explained elsewhere (Godefroy-Colburn et al., 1990; Schoumacher et al., 1992) and dialysed against PBS (0.15 M-NaC1, 1.5 mM-KH2PO4, 7-9 mM-Na2HPO4, pH 7-5)containing 0.1~ Tween 20. A rabbit was injected subcutaneously four times at 3-week intervals, with 10, 30, 15 and 100 gg respectively of purified protein in 0.5 ml of PBS-Tween with complete (first injection) or incomplete Freund's adjuvant (boosters). Serum was prepared from blood collected 10 days after the last injection and kept at -20 °C in 50~ glycerol. Its specificity was ascertained by Western blotting, using extracts from A1MV-infected leaves as test material (not shown). This antiserum (designated anti-P3) was five to ten times as efficient as the anti-PEP3 serum, raised against a C-terminal peptide of P3 .
Analysis of total proteins from yeast or tobacco leaves. Transformed yeast was extracted by using NaOH and 2-mercaptoethanol and the proteins were precipitated with TCA as in Yaffe & Schatz (1984) . The pellet was washed with acetone and redissolved at 100°C in electrophoresis sample buffer (ESB; 6 M-urea, 3~ SDS, 5% 2-mercaptoethanol, 0.03~ bromophenol blue in 50 mM-Tris-HC1 buffer pH 6.8). Leaf samples (100 mg) were finely ground in liquid nitrogen, then were extracted at 100°C for 10 rain in 100 gl of 1.5-fold concentrated ESB. The extracts were clarified by centrifugation at 10000 g for 5 min and analysed by SDS-PAGE in 10~ gels and Western blotting . Immunodetection of P3 was with the anti-PEP3 serum, diluted 2000-fold, or with the anti-P3 serum, diluted 3000-fold.
Fractionation of leaf extracts. The normal and transgenic plants, grown in parallel, were used 6 to 7 weeks after sowing. A1MV was manually inoculated to normal plants (Pinck & Hirth, 1972) and the infection was allowed to develop at 25 °C in a high-humidity chamber under 16 h illumination. Extraction of AIMV-infected or transgenic leaves and fractionation of the leaf extracts were essentially as described in Moser et al. (1988) . Briefly, the leaves were finely sliced in grinding buffer (GB; 10 mM-KCI, 5 mM-MgCI2, 0.4 M-sucrose, 10~ glycerol, 10 mr~-2-mercaptoethanol in 100 mM-Tris-HC1 buffer pH 8.1 at 4 °C). The slurry was filtered through a nylon screen and the filtrate was centrifuged at 30000 g to give the 30000 g pellet (P) and supernatant (S) fractions. The filtration residue was extracted three times with GB containing 1 ~ Triton X-100. The Triton extracts were combined to give fraction T and the residue (fraction W, mainly containing cell walls) was extracted with ESB at 100 °C.
Results and Discussion
Three DNA fragments coding respectively for the fulllength MP and for truncated MPs lacking 12 or 77 Nterminal amino acids were prepared from a complete clone of RNA3. The expression of these DNA fragments (more specifically the ability of eukaryotic ribosomes to initiate translation at the second and sixth methionine residues of P3), and the stability of the proteins expressed from them, were tested in S. cerevisiae. Fig. 1 (a) shows that the yeast transformed with pVT.P3, pVT.P3A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] or pVT. P3A[ 1-77] expressed properly terminated P3-related proteins and that the major products were of Having ascertained that the D N A fragments derived from the P 3 0 R F were functional in yeast, they were used to transform tobacco plants. Fig. l (b) shows that the major product of the full-length O R F (lane l) had the same mobility as virally induced P3 (lanes V and V') and that the major product induced in plants by each deleted gene (lanes 3 and 5) had the same mobility as that induced in yeast (lanes 2 and 4) . The amount of protein expressed from the chimeric gene varied significantly from plant to plant but the average level of expression (evaluated by analysis of 10 to 20 plants of the R0 generation expressing each construct) was higher for P3A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] than for either P3 or P3A . The products made by plants transformed with pMON.P3A were heterogeneous, possibly as a result of degradation or internal initiation. It should be noted that previous attempts at transforming tobacco with the A1MV MP gene produced transgenic plants in which P3 synthesis was undetectable (Dore et al., 1991) .
The localization of the P3-related proteins in transgenic plants was assayed by subcellular fractionation. To rule out the effect of the age of the tissue on localization, which has been reported for the T M V MP (Deom et al., 1990) , the fractionation was carried out with two types of leaves: very young leaves (approximately 3 cm in length) and mature ones, equivalent respectively to the first and the sixth leaves described in Deom et al. (1990) . Samples taken from transgenic tobacco plants expressing P3, P3A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] or P3A were processed in parallel with an A1MV-inoculated leaf (equivalent to the sixth leaf) removed from the plant 2 days after manual inoculation, and with a systemically infected leaf (equivalent to the first leaf) showing vein-clearing symptoms and removed 6 days after inoculation. The four fractions obtained from each sample (P, S, T and W, as defined in Methods) accounted for all the leaf material. Equivalent amounts of these fractions were analysed by S D S -P A G E and Western blotting.
In contrast with the T M V MP (Deom et al., 1990) , neither P3 nor the deleted proteins derived from it were detected in fraction S in significant amounts (less than 10~ of the total; data not shown). In the control A1MV-infected plant, a slightly higher amount of P3 was found in the cell wall fraction of primary infected leaves (Fig.  2a) than of young leaves (Fig. 2b) whereas, as noted earlier (Godefroy-Colburn et al., 1991) , the cytoplasmic pool of P3 was much larger in the latter than in the former. The MP being rather unstable in AlMV-infected tobacco leaves (Godefroy-Colburn et al., 1986; StussiGaraud et al., 1987) , this may be an indication that a larger number of cells were actively synthesizing P3 at the time of sampling in the systemically infected leaves than in the manually inoculated ones. In transgenic plants, in contrast with the results of Deom et al. (1990) , mature and young leaves gave essentially the same fractionation patterns and consequently we only present the fractionation of young leaves (Fig. 2c to e) . In the plants expressing the full-length MP (Fig. 2c) , most of the protein was found in fraction W. The deleted protein analysed by SDS-PAGE in 10~ gels, followed by a Western blot assay using the anti-P3 serum.
P3A [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] had the same fractionation pattern as P3 (Fig.  2d ) but P3A [I-77] was found mainly in cytoplasmic fraction P (Fig. 2e) . Some of the P3-related proteins present in lanes 2 of Fig. 2 (b to d) (fraction T) may originate from contamination by cytoplasmic and/or cell wall material. However, fraction T may also contain a specific pool of proteins which were not released from the cell wall fraction by detergent-free buffers because they were associated with membranes embedded into the cell wall, such as the plasmodesmatal membranes. The localization of the full-length and truncated MPs in transgenic plants is being studied in more detail by immunoelectron microscopy. The above results suggest that 12 N-terminal amino acids of P3 are not required for targeting the protein to the cell wall but that a domain located between amino acids 13 and 77 is needed. This domain could direct the protein to the export system or more specifically to the cell wall/plasmodesma compartment, or else be involved in the recognition of a putative receptor. However, our results do not prove that amino acids 13 to 77 contain a true targeting sequence, acting independently of the rest of the protein. Alternatively, the data can be explained by assuming that this region is involved in maintaining another part of the molecule in the proper conformation. The fact that P3A was associated with a cytoplasmic particulate fraction and was not present in fraction S suggests that the truncated protein did interact with some membranes although it did not follow the normal export pathway throughout. Amino acids 13 to 77 do contain a stretch of 20 uncharged amino acids (Fig 3; amino acids 49 to 68) of sufficient length and hydrophobicity to qualify as a transmembrane domain (Engelman et al., 1986) . This domain could direct the protein to the plasma membrane, a likely intermediate for interaction (1986) , using the Pepplot program of the University of Wisconsin Computer Group (Devereux et al., 1984) . Regions with high propensity for ~t-helical and fl-turn conformations (Chou & Fasman, 1978) are indicated by the open and the solid bars respectively. with cell walls or plasmodesmata. In its absence, however, shorter hydrophobic domains located elsewhere in the molecule (e.g. around amino acids 95 or 170) might be sufficient for interaction with thinner membranes such as those of the endoplasmic reticulum or of the tonoplast. Examples of such modified targeting have been reported (Engelman et al., 1986) . In addition to the hydrophobic domain (49 to 68), amino acids 13 to 77 show some interesting features: (i) a negatively charged a-helix (amino acids 23 to 34), (ii) a well defined fl-turn centred at amino acid 45 and (iii) the beginning of a positively charged domain (amino acids 69 to 90). The negative ~-helix seems to have the same characteristics as a C-proximal domain involved in cell wall localization of the MP of T M V (amino acids i 95 to 213) . However, complete removal of the negatively charged a-helix has a different effect on the stability of the A1MV and T M V MPs. Indeed, P3A was found in extracts of our transgenic plants, together with some smaller products, whereas the C-terminally deleted MPs of T M V which completely lacked the a-helix were not detected in plants . Additional deletions would be needed to define more precisely the domains involved in targeting P3 to the cell wall. We are currently testing our transgenic lines for their ability to complement the movement function of an MP-deficient AIMV inoculum. This will tell us whether the full-length MP made by transgenic plants does indeed reach its functional location.
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